Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on September 10, 2026

Sep. 10, 2026

BWT Alpine Formula One Team and SEALSQ advance Formula One’s First Quantum Security Partnership with Hybrid Quantum-Classical Simulation

Indeterminate GlobeNewswire

Sep. 10, 2026

electroCore to Participate at H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire

Sep. 10, 2026

Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting

Indeterminate GlobeNewswire

Sep. 10, 2026

Rezolve Ai to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 10, 2026

Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy

Indeterminate GlobeNewswire

Sep. 10, 2026

Percona and Coroot Partner to Bring Full-Stack Observability to Open Source Database Environments

Indeterminate GlobeNewswire

Sep. 10, 2026

Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth

Indeterminate GlobeNewswire

Sep. 10, 2026

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

Indeterminate GlobeNewswire

Sep. 10, 2026

Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose

Indeterminate GlobeNewswire

Sep. 10, 2026

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

Indeterminate GlobeNewswire

Sep. 10, 2026

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

Indeterminate GlobeNewswire

Sep. 10, 2026

Cloudera and Mistral Partner to Bring Specialized, Sovereign Intelligence to Enterprise Data

Indeterminate GlobeNewswire

Sep. 10, 2026

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 10, 2026

Burning Rock Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Sep. 10, 2026

Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment

Indeterminate GlobeNewswire

Sep. 10, 2026

SOPRIS TECHNOLOGIES Launches Moneytoring® on Google Cloud Marketplace, Offering Comprehensive Business Observability

Indeterminate GlobeNewswire

Sep. 10, 2026

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader

Indeterminate GlobeNewswire

Sep. 10, 2026

New AI Solution Helps Utilities Address More Than $180B in Capital Accounting Backlog

Indeterminate GlobeNewswire

Sep. 10, 2026

Long-Acting Oligonucleotide Development: Dosing, Yield and Stability Questions

Indeterminate GlobeNewswire

Sep. 10, 2026

Actithera significantly strengthens leadership team and Board as Company advances towards clinical development

Indeterminate GlobeNewswire